native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity](https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41573-025-01183-8/MediaObjects/41573_2025_1183_Fig4_HTML.png)
![native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X13006082-gr1.jpg)
![native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-024-01931-z/MediaObjects/41392_2024_1931_Fig5_HTML.png)
![native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity](https://www.nativemed.net/cdn/shop/files/Banner-02_3_1.webp?v=1733124661&width=1500)
![native glp-1 Oral Small-Molecule Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies[v1] GLP-1-based therapies for diabetes, obesity](https://www.researchgate.net/publication/41422599/figure/fig1/AS:11431281256338552@1719524381886/Structures-of-native-GLP-1-exenatide-and-liraglutide-The-N-terminal-dipeptide-HA-in.jpg)

























